Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Hypnosis × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Anxiety Disorders 4 Neoplasms 3 Depression 2 Uterine Cervical Neoplasms 1 Pulmonary Disease, Chronic Obstructive 1 Lung Diseases, Interstitial 1 Leukemia, Myeloid, Acute 1 Head and Neck Neoplasms 1 Dyspnea 1 Breast Neoplasms 1

Interventions

pembrolizumab 49 Cisplatin 38 Radiotherapy 24 Cetuximab 22 Carboplatin 20 Nivolumab 15 Paclitaxel 14 Docetaxel 14 Surveys and Questionnaires 11 Fluorouracil 11 Drug Therapy 10 Blood Specimen Collection 10 Radiotherapy, Intensity-Modulated 8 tislelizumab 7 atezolizumab 6 Radiation 6 Standard of Care 5 Afatinib 5 cemiplimab 4 Chemoradiotherapy 4 toripalimab 3 palbociclib 3 dostarlimab 3 Surgical Procedures, Operative 3 Magnetic Resonance Spectroscopy 3 Immune Checkpoint Inhibitors 3 Fulvestrant 3 Erlotinib Hydrochloride 3 Equipment and Supplies 3 Capecitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04671485 2025-07-24

HYMACO

Institut de Cancérologie de Lorraine

Phase NA Completed

Anxiety Disorders, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡